Metaraminol-induced coronary vasospasm masquerading as ST-elevation myocardial infarction during general anaesthesia

Br J Anaesth. 2024 May;132(5):998-1000. doi: 10.1016/j.bja.2024.01.045. Epub 2024 Mar 23.

Authors

Joshua G Kovoor¹, Daniel Gorman², Neil Warwick², Gopal Sivagangabalan³, Pramesh Kovoor⁴

Affiliations

¹ The University of Adelaide, Adelaide, SA, Australia; Ballarat Base Hospital, Ballarat, VIC, Australia.
² Westmead Hospital and Westmead Private Hospital, Sydney, NSW, Australia.
³ Westmead and Auburn Hospitals, University of Notre Dame, Sydney, NSW, Australia.
⁴ Westmead Hospital and Westmead Private Hospital, University of Sydney, Sydney, NSW, Australia. Electronic address: pramesh.kovoor@sydney.edu.au.

PMID: 38521657
DOI: 10.1016/j.bja.2024.01.045

No abstract available

Keywords: ST-elevation myocardial infarction; anaesthesia; coronary vasospasm; glyceryl trinitrate; metaraminol.

Publication types

Letter

MeSH terms

Anesthesia, General / adverse effects
Coronary Angiography
Coronary Vasospasm* / chemically induced
Coronary Vasospasm* / diagnosis
Electrocardiography
Humans
Metaraminol
Myocardial Infarction*
Percutaneous Coronary Intervention*
ST Elevation Myocardial Infarction* / diagnosis

Substances

Metaraminol